Executive Summary
Strong viability across all dimensions with clear path to market.
One-Line Summary
Clinical Trial Navigator: A mobile-first platform simplifying clinical trial discovery and eligibility tracking for patients and caregivers.
Core Problem Solved
Finding clinical trials is a daunting task for patients due to the overwhelming number of studies listed on ClinicalTrials.gov, often written in complex medical jargon. Many patients miss life-changing opportunities because they are unaware of trials available for their condition, struggle to understand eligibility criteria, lack a system to track trials, and face geographic and logistical barriers. Addressing these challenges, Clinical Trial Navigator empowers patients and caregivers to discover, understand, and engage with relevant trials effectively.
Primary Audience
The primary audience includes patients with chronic or serious health conditions such as cancer, rare diseases, and autoimmune disorders. Secondary users are caregivers seeking treatment options for family members, particularly for elderly parents or children with rare conditions. The estimated market size comprises over 50 million Americans with chronic conditions, indicating a substantial target demographic.
Market Size Breakdown
TAM: $2B+ global clinical trial recruitment market
SAM: $500M U.S. market for patient-centric trial discovery tools
SOM: $50M (10% market share within 3 years)
Market Timing ("Why Now?")
Technological advancements in AI and mobile platforms enable the creation of intuitive, user-friendly tools like Clinical Trial Navigator. There's a growing demand for patient empowerment in healthcare decisions, driven by increasing awareness and chronic condition prevalence. Additionally, pharma companies face significant recruitment challenges, creating a timely opportunity for innovative recruitment solutions.
Competitive Positioning Matrix
[Your Solution]
[ClinicalTrials.gov] [TrialSpark]
[Your Solution]
[ClinicalTrials.gov] [TrialSpark]
Clinical Trial Navigator offers personalized, patient-centric features that distinguish it from generic, pharma-focused competitors.
Financial Snapshot
- Estimated MVP Development Cost: $250K - $500K
- Revenue Model: Freemium SaaS with premium features at $9.99/month
- Break-Even Timeline: 18 months
- Unit Economics Preview: LTV:CAC ratio target of 5:1
Top 3 Highlights
Market Opportunity: The platform addresses a significant gap in the $2B+ clinical trial recruitment market, focusing on patient empowerment.
Technical Innovation: Utilizes AI for smart matching and plain language summaries, enhancing user experience and accessibility.
Business Model: A freemium SaaS model with potential B2B partnerships for pharma and CROs, ensuring diverse revenue streams.
Overall Viability Scores
Critical Success Factors
- Accurate AI-driven eligibility matching
- User-friendly interface and mobile experience
- Strong partnerships with pharma and CROs
Key Risks & Mitigations
- Risk: Medical advice liability | Mitigation: Clear disclaimers, encourage physician consultation
- Risk: Data accuracy | Mitigation: Regular sync with official sources, user feedback loop
- Risk: Pharma perception | Mitigation: Transparent partnerships, patient interests prioritized
Success Metrics (First 6 Months)
- Monthly Active Users: 10,000+
- Trial Matches per User: 3+ matches
- Premium Conversion Rate: 20%
Recommended Next Steps
- Week 1-2: Develop MVP with core features
- Week 3: Conduct user interviews and gather feedback
- Week 4-8: Launch beta with select patient groups
- Week 9-12: Refine based on beta feedback
- Week 13-16: Official launch and marketing campaign